,

Allegro Ophthalmics
Coming October 12

This Insight Is Leading To Better Eyesight

Date & Time


October 12, 12:00 PM ET / 9:00 AM PT

About the Event


Allegro Ophthalmics has developed RSG, a synthetic peptide that targets inflammation and stress in the eye to treat Dry AMD and Dry Eye Disease, serious conditions that affect more than 30 million people in the U.S. alone.

  • In Phase 2a clinical tests, Dry AMD a plurality patients taking RSG showed significant improvement in visual acuity.
  • Dry Eye Disease patients are seeing similar results including a decrease in eye dryness score by more than 70 points. 

Join our webinar with Vicken Karageozian, MD, CEO and President of Allegro Ophthalmics, to hear more about this amazing breakthrough and the path toward FDA approval for RSG.

Sign Up For This Event


SHARE THIS EVENT

All statements and expressions are the sole opinion of the company and are subject to change without notice. The Company is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial advisor, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. Information contained herein contains “forward looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities and Exchange Act of 1934, as amended. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be “forward looking statements”. Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of words such as “expects”, “will”, “anticipates”, “estimates”, “believes”, or by statements indicating certain actions “may”, “could”, “should” or “might” occur.